Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for preoperative anxiety in gynecological laparoscopy and hysteroscopy
ChiCTR2600128893Phase 4Not yet recruiting
- Sponsor
- Huai'an First People's Hospital
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in preoperative anxiety (2 arms), sponsored by Huai'an First People's Hospital. Primary endpoint: Change in State Anxiety Inventory-State score (T2 - T0). Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2600128893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600128893.